2024 ICD-10-CM Diagnosis Code L92.9

Granulomatous disorder of the skin and subcutaneous tissue, unspecified

ICD-10-CM Code:
L92.9
ICD-10 Code for:
Granulomatous disorder of the skin, subcu, unsp
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Not chronic
Code Navigator:

Code Classification

  • Diseases of the skin and subcutaneous tissue
    (L00–L99)
    • Other disorders of the skin and subcutaneous tissue
      (L80-L99)
      • Granulomatous disorders of skin and subcutaneous tissue
        (L92)

L92.9 is a billable diagnosis code used to specify a medical diagnosis of granulomatous disorder of the skin and subcutaneous tissue, unspecified. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

Unspecified diagnosis codes like L92.9 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Abnormal granulation tissue
  • Combined immunodeficiency with granulomatosis
  • Granulation of skin
  • Granulation tissue at vaginal vault
  • Granuloma of buttock
  • Granuloma of lip
  • Granuloma of surgical wound
  • Granulomatosis
  • Granulomatous disorder of the skin and subcutaneous tissue
  • Nodule of buttock
  • Over-granulating secondary intention surgical wound
  • Restrictive cardiomyopathy secondary to granulomas
  • Secondary restrictive cardiomyopathy
  • Stomal granuloma
  • Vaginal granulation tissue
  • Wound granuloma
  • Wound granuloma
  • Wound granuloma
  • Wound inflammation
  • Wound inflammation
  • Wound inflammation

Clinical Classification

Clinical Information

  • Adult Grade III Lymphomatoid Granulomatosis|Grade III Lymphomatoid Granulomatosis

    grade iii lymphomatoid granulomatosis that occurs in adulthood.
  • Central Nervous System Lymphomatoid Granulomatosis

    lymphomatoid granulomatosis that affects the brain, spinal cord, and leptomeninges.
  • Childhood Grade III Lymphomatoid Granulomatosis|Grade III Lymphomatoid Granulomatosis

    grade iii lymphomatoid granulomatosis that occurs during childhood.
  • Childhood Lymphomatoid Granulomatosis

    lymphomatoid granulomatosis that occurs during childhood.
  • Cutaneous Lymphomatoid Granulomatosis

    lymphomatoid granulomatosis that affects the skin.
  • Eosinophilic Granulomatosis with Polyangiitis|Allergic Granulomatosis|Allergic Granulomatous Angiitis|Churg-Strauss Syndrome|EGPA|Polyarteritis with lung involvement [Churg-Strauss]

    an autoimmune necrotizing vasculitis with the formation of granulomas. it is a pulmonary and systemic vasculitis associated with eosinophilia.
  • Erdheim-Chester Disease|ECD|Lipogranulomatosis|Polyostotic Sclerosing Histiocytosis

    a very rare, multisystem non-langerhans cell histiocytosis that predominantly affects adults. it is characterized by the proliferation in the tissues of lipid-laden macrophages and the presence of multinucleated giant cells. it results in sclerosis of the long bones and failure of the affected organs. patients may present with bone pain, exophthalmos, ataxia, liver failure, kidney failure, and hypopituitarism.
  • Farber Lipogranulomatosis

    a very rare autosomal recessive metabolic disorder affecting lipid metabolism. it is caused by mutations in the asah1 gene and is characterized by fatty accumulation in the body tissues. patients develop lipogranulomas in the skin and internal organs, edema and pain in the joints and a hoarse voice. it may be associated with intellectual disability.
  • Grade I Lymphomatoid Granulomatosis|Angiocentric Immunoproliferative Lesion Grade I|Grade I Angiocentric Immunoproliferative Lesion|Grade I Angiocentric Immunoproliferative Lesions|Grade I LYG

    lymphomatoid granulomatosis characterized by the presence of a polymorphous lymphoid infiltrate without cytologic atypia. large lymphocytes are absent or rare. by in situ hybridization, ebv-positive cells are infrequently seen.
  • Grade II Lymphomatoid Granulomatosis|Angiocentric Immunoproliferative Lesion Grade II|Grade II Angiocentric Immunoproliferative Lesion|Grade II Angiocentric Immunoproliferative Lesions|Grade II LYG

    lymphomatoid granulomatosis characterized by the presence of occasional large lymphoid cells or immunoblasts in a polymorphous background. necrosis is more commonly seen as compared to grade i lymphomatoid granulomatosis. by in situ hybridization, ebv-positive cells are readily seen.
  • Grade III Lymphomatoid Granulomatosis|Angiocentric Immunoproliferative Lesion Grade III|Grade III Angiocentric Immunoproliferative Lesion|Grade III Angiocentric Immunoproliferative Lesions|Grade III LYG

    lymphomatoid granulomatosis characterized by the presence of aggregates of neoplastic large b-lymphocytes, usually admixed with pleomorphic and hodgkin-like cells, in a background of chronic inflammation. necrotic changes are present and are usually extensive. grade iii lymphomatoid granulomatosis should be approached clinically as a subtype of diffuse large b-cell lymphoma.
  • Granulomatosis

    a general term that refers to non-neoplastic and neoplastic disorders characterized by the presence of granulomas in various anatomic sites.
  • Granulomatosis with Polyangiitis|GPA|GPA|Wegener Granulomatosis|Wegener Granulomatosis|Wegener's Granulomatosis|Wegener's Granulomatosis

    a rare, autoimmune, systemic medium and small size vasculitis. it is characterized by the formation of necrotizing granulomas in the respiratory tract, necrotizing angiitis, and glomerulonephritis.
  • Langerhans Cell Histiocytosis|Histiocytosis X|Histiocytosis X|LCH|LCH|Langerhans Cell Granulomatosis|Langerhans cell granulomatosis|Langerhans cell histiocytosis|Langerhans cell histiocytosis|Langerhans cell histiocytosis, NOS

    a neoplastic proliferation of langerhans cells which contain birbeck granules by ultrastructural examination. three major overlapping syndromes are recognized: eosinophilic granuloma, letterer-siwe disease, and hand-schuller-christian disease. the clinical course is generally related to the number of organs affected at presentation. (who, 2001)
  • Lymphomatoid Granulomatosis|LYG|Lymphomatoid granulomatosis|Lymphomatoid granulomatosis|lymphomatoid granulomatosis

    an angiocentric and angiodestructive lymphoproliferative disease involving extranodal sites, comprised of epstein-barr virus (ebv)-positive b-cells admixed with reactive t-cells. incidence is higher among adult males; patients with a history of immunodeficiency are at increased risk. the most common site of involvement is the lung; other common sites include brain, kidney, liver, and skin. morphologically, three grades are recognized: grade i, ii, and iii. grade iii lymphomatoid granulomatosis should be approached clinically as a subtype of diffuse large b-cell lymphoma.
  • Myeloblastin|ACPA|AGP7|Azurophil Granule Protein 7|C-ANCA|C-ANCA Antigen|EC 3.4.21.76|Leukocyte Proteinase 3|MBT|NP-4|Neutrophil Proteinase 4|Neutrophil Serine Proteinase|P29|PR-3|PR3|PR3|PROTEINASE 3|PRTN3|Proteinase 3|Serine Proteinase, Neutrophil|Wegener Autoantigen|Wegener Granulomatosis Autoantigen|Wegener Granulomatosis Autoantigen|p29

    myeloblastin (256 aa, ~28 kda) is encoded by the human prtn3 gene. this protein is involved in the proteolysis of extracellular matrix proteins.
  • Pauci-Immune Glomerulonephritis associated with Eosinophilic Granulomatosis with Polyangiitis|Churg-Strauss Syndrome Associated Glomerulonephritis|Pauci-immune Glomerulonephritis associated with Eosinophilic Granulomatosis with Polyangiitis

    glomerulonephritis in the context of eosinophilic-rich granulomatosis with polyangiitis, eosinophilia, asthma and commonly anti-neutrophil cytoplasmic antibody.
  • Pauci-Immune Glomerulonephritis associated with Granulomatosis with Polyangiitis|Pauci-immune Glomerulonephritis associated with Granulomatosis with Polyangiitis

    glomerulonephritis in the context of granulomatosis with polyangiitis in which anti-neutrophil cytoplasm antibody (anca) is almost always present.
  • PRTN3 Gene|PRTN3|PRTN3|Proteinase 3 (Serine Proteinase, Neutrophil, Wegener Granulomatosis Autoantigen) Gene

    this gene plays a role in the growth of hematopoietic cells.
  • PRTN3 wt Allele|ACPA|AGP7|MBN|MBT|PR3|Proteinase 3 (Serine Proteinase, Neutrophil, Wegener Granulomatosis Autoantigen) wt Allele

    human prtn3 wild-type allele is located in the vicinity of 19p13.3 and is approximately 7 kb in length. this allele, which encodes myeloblastin protein, plays a role in the induction of factor-independent growth of hematopoietic cells. overexpression of the prtn3 gene is associated with wegener granulomatosis.
  • Pulmonary Lymphomatoid Granulomatosis|Lung Lymphomatoid Granulomatosis

    a rare lymphoproliferative disorder that affects the lungs. it is characterized by the presence of an angiocentric and angiodestructive polymorphic cellular infiltrate composed of ebv-positive neoplastic b-lymphocytes and reactive t-lymphocytes. the majority of patients present with bilateral nodular lesions in the lungs. the prognosis depends on the histologic grade of the lesions. one third of patients with grade 1 lesions and two thirds of patients with grade 2 lesions progress to non-hodgkin lymphoma. grade 3 lesions, by definition, are classified as non-hodgkin lymphomas.
  • Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Grade III Lymphomatoid Granulomatosis

    the reemergence of grade iii lymphomatoid granulomatosis in adulthood after a period of remission.
  • Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Grade III Lymphomatoid Granulomatosis

    the reemergence of grade iii lymphomatoid granulomatosis in childhood after a period of remission.
  • Recurrent Childhood Lymphomatoid Granulomatosis

    the reemergence of lymphomatoid granulomatosis in childhood after a period of remission.
  • Recurrent Grade I Lymphomatoid Granulomatosis

    the reemergence of grade i lymphomatoid granulomatosis after a period of remission.
  • Recurrent Grade II Lymphomatoid Granulomatosis

    the reemergence of grade ii lymphomatoid granulomatosis after a period of remission.
  • Wegener's Granulomatosis with Renal Involvement|Wegener's granulomatosis with renal involvement

    evidence of wegener's granulomatosis with renal involvement.
  • Wegener's Granulomatosis without Renal Involvement|Wegener's granulomatosis without renal involvement

    evidence of wegener's granulomatosis without renal involvement.

Tabular List of Diseases and Injuries

The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.


Type 2 Excludes

Type 2 Excludes
A type 2 excludes note represents "Not included here". An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.

Index to Diseases and Injuries References

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

Convert L92.9 to ICD-9-CM

  • ICD-9-CM Code: 701.5 - Abnormal granulation NEC
    Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Patient Education


Skin Conditions

What does your skin do?

Your skin is your body's largest organ. It covers the entire outside of your body. There are many ways that your skin protects your body and helps keep you healthy. For example, it:

  • Holds body fluids in, which helps prevent you from getting dehydrated
  • Keeps out harmful germs, which helps prevent infections
  • Helps you feel things like heat, cold, and pain
  • Helps control your body temperature
  • Makes vitamin D when the sun shines on it
  • Shields your body against heat and light

What problems and conditions can affect your skin?

There are many different problems and conditions which can affect your skin. Some of them can cause uncomfortable symptoms, such as itching, burning, redness, and rashes. They might also affect your appearance. Some of the more common skin conditions include:

  • Acne, which causes pimples when hair follicles under your skin get clogged up
  • Burns
  • Cuts and scrapes
  • Dandruff, flaking of the skin on your scalp (the top of your head)
  • Eczema (atopic dermatitis), which causes inflammation, redness, and irritation of the skin
  • Hives, which are red and sometimes itchy bumps on your skin
  • Insect bites
  • Psoriasis, which causes itchy, scaly red patches
  • Skin cancer
  • Skin infections

How can I keep my skin healthy?

Since your skin protects your body in many ways, it's important to try to keep your skin healthy. For example, you can:

  • Wear the right protective equipment, like gloves, long sleeves, knee and elbow pads, or helmets to protect against cuts, bumps and scrapes.
  • If you do get a cut or scrape, clean it right away with soap and warm water. Put on a bandage to protect it while it heals.
  • When you are spending time outdoors, wear long sleeves and pants and use insect repellant to prevent insect bites.
  • Prevent sunburn by covering up and using sunscreen when outdoors.
  • Wash your hands often with soap and water.
  • When you take a shower or bath, use warm (not hot) water. Use mild cleansers and wash gently (don't scrub).
  • Use moisturizers, like lotions, creams, or ointments, to prevent dry skin.

NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.